Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -192.08% is 73% above its 5-year average of -698.72%, near the high end of its 5-year range (-1964.74%–94.41%).
65.39% above its 12-month average of -554.98%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -588.17%.
OPERATING MARGIN
-192.08%
OPERATING MARGIN AVG TTM
-554.98%
OPERATING MARGIN AVG 3Y
-889.67%
OPERATING MARGIN AVG 5Y
-698.72%
OPERATING MARGIN AVG 10Y
-1094.35%
OPERATING MARGIN AVG 15Y
-763.88%
OPERATING MARGIN AVG 20Y
-518.35%
CURRENT VS TTM AVG
+65.39%
CURRENT VS 3Y AVG
+78.41%
CURRENT VS 5Y AVG
+72.51%
CURRENT VS 10Y AVG
+82.45%
CURRENT VS 15Y AVG
+74.85%
CURRENT VS 20Y AVG
+62.94%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Arbutus Biopharma Corp
Market Cap
$922.50M
Operating Margin
-192.08%
TTM Avg
-554.98%
3Y Avg
-889.67%
5Y Avg
-698.72%
Market Cap
$921.45M
Operating Margin
8.04%
TTM Avg
6.98%
3Y Avg
6.09%
5Y Avg
5.66%
Market Cap
$915.95M
Operating Margin
10.63%
TTM Avg
4.11%
3Y Avg
-10.10%
5Y Avg
-5.16%
Market Cap
$903.13M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$943.26M
Operating Margin
-68.62%
TTM Avg
-63.13%
3Y Avg
-82.91%
5Y Avg
-82.91%
Market Cap
$867.60M
Operating Margin
-43.83%
TTM Avg
-75.55%
3Y Avg
-37.77%
5Y Avg
-25.18%
Market Cap
$985.79M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-59.79%
Market Cap
$989.05M
Operating Margin
-1149.52%
TTM Avg
-2324.93%
3Y Avg
-1162.47%
5Y Avg
-1162.47%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $922.50M | -192.08% | -554.98% | -889.67% | -698.72% |
| HealthStream, Inc. (HSTM)vs › | $921.45M | 8.04% | 6.98% | 6.09% | 5.66% |
| Bioventus Inc. (BVS)vs › | $915.95M | 10.63% | 4.11% | -10.10% | -5.16% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| CeriBell, Inc. (CBLL)vs › | $943.26M | -68.62% | -63.13% | -82.91% | -82.91% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | -43.83% | -75.55% | -37.77% | -25.18% |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $985.79M | 0.00% | 0.00% | 0.00% | -59.79% |
| Aktis Oncology, Inc. (AKTS)vs › | $989.05M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
| Beta Bionics, Inc. (BBNX)vs › | $852.55M | -69.75% | -70.49% | -9306.05% | -9306.05% |
Gross Margin
100.0%
Operating Margin
-192.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -588.17% |
| 2026-03-31 | 94.41% |
| 2025-12-31 | -727.31% |
| 2025-09-30 | -1567.67% |
| 2025-06-30 | 13.86% |
| 2025-03-31 | -1964.74% |
| 2024-12-31 | -885.20% |
| 2024-09-30 | -1601.19% |
| 2024-06-30 | -1250.46% |
| 2024-03-31 | -1263.90% |
| 2023-12-31 | -967.23% |
| 2023-09-30 | -462.82% |
| 2023-06-30 | -395.29% |
| 2023-03-31 | -260.40% |
| 2022-12-31 | -361.28% |
| 2022-09-30 | -299.24% |
| 2022-06-30 | -99.07% |
| 2022-03-31 | -87.23% |
| 2021-12-31 | -648.66% |
| 2021-09-30 | -551.14% |
| 2021-06-30 | -800.43% |
| 2021-03-31 | -741.88% |
| 2020-12-31 | -683.19% |
| 2020-09-30 | -999.15% |
| 2020-06-30 | -867.97% |
| 2020-03-31 | -881.76% |
| 2019-12-31 | -805.62% |
| 2019-09-30 | -2985.98% |
| 2019-06-30 | -3141.65% |
| 2019-03-31 | -2808.69% |
| 2018-12-31 | -1007.33% |
| 2018-09-30 | -2043.23% |
| 2018-06-30 | -1772.19% |
| 2018-03-31 | -1281.69% |
| 2017-12-31 | -2377.62% |
| 2017-09-30 | -187.13% |
| 2017-06-30 | -1875.36% |
| 2017-03-31 | -7786.81% |
| 2016-12-31 | 132020.00% |
| 2016-09-30 | -2451.55% |
| 2016-06-30 | -63187.06% |
| 2016-03-31 | -3312.94% |
| 2015-12-31 | -92.68% |
| 2015-09-30 | -1430.21% |
| 2015-06-30 | -423.53% |
| 2015-03-31 | -384.58% |
| 2014-12-31 | -247.06% |
| 2014-09-30 | -156.90% |
| 2014-06-30 | -520.32% |
| 2014-03-31 | -134.49% |
| 2013-12-31 | -32.52% |
| 2013-09-30 | -123.27% |
| 2013-06-30 | -107.99% |
| 2013-03-31 | -140.45% |
| 2012-12-31 | -155.59% |
| 2012-09-30 | -58.18% |
| 2012-06-30 | -71.34% |
| 2012-03-31 | -73.93% |
| 2011-12-31 | -58.16% |
| 2011-09-30 | -40.43% |
| 2011-06-30 | -82.20% |
| 2011-03-31 | -70.83% |
| 2010-12-31 | -108.38% |
| 2010-09-30 | 30.60% |
| 2010-06-30 | -179.89% |
| 2010-03-31 | -181.57% |
| 2009-12-31 | -55.62% |
| 2009-09-30 | -79.00% |
| 2009-06-30 | -59.03% |
| 2009-03-31 | -76.56% |
| 2008-12-31 | -173.49% |
| 2008-09-30 | -66.55% |
| 2008-06-30 | -206.77% |
| 2008-03-31 | -45.40% |
| 2007-12-31 | 2.00% |
| 2007-09-30 | 28.69% |
| 2007-06-30 | 6.49% |
